- Home
- NRXS vs BFRG Comparison
NRXS vs BFRG Comparison
Compare NRXS & BFRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXS
- BFRG
- Stock Information
- Founded
- NRXS 2011
- BFRG 2017
- Country
- NRXS United States
- BFRG United States
- Employees
- NRXS N/A
- BFRG N/A
- Industry
- NRXS
- BFRG Retail: Computer Software & Peripheral Equipment
- Sector
- NRXS
- BFRG Technology
- Exchange
- NRXS Nasdaq
- BFRG Nasdaq
- Market Cap
- NRXS 20.3M
- BFRG 21.2M
- IPO Year
- NRXS 2023
- BFRG 2023
- Fundamental
- Price
- NRXS $3.15
- BFRG $2.28
- Analyst Decision
- NRXS
- BFRG
- Analyst Count
- NRXS 0
- BFRG 0
- Target Price
- NRXS N/A
- BFRG N/A
- AVG Volume (30 Days)
- NRXS 23.3K
- BFRG 68.4K
- Earning Date
- NRXS 11-12-2024
- BFRG 11-08-2024
- Dividend Yield
- NRXS N/A
- BFRG N/A
- EPS Growth
- NRXS N/A
- BFRG N/A
- EPS
- NRXS N/A
- BFRG N/A
- Revenue
- NRXS $2,456,219.00
- BFRG N/A
- Revenue This Year
- NRXS $383.16
- BFRG N/A
- Revenue Next Year
- NRXS N/A
- BFRG N/A
- P/E Ratio
- NRXS N/A
- BFRG N/A
- Revenue Growth
- NRXS N/A
- BFRG 550.00
- 52 Week Low
- NRXS $2.00
- BFRG $1.43
- 52 Week High
- NRXS $3.89
- BFRG $8.35
- Technical
- Relative Strength Index (RSI)
- NRXS 59.42
- BFRG 41.21
- Support Level
- NRXS $2.25
- BFRG $2.18
- Resistance Level
- NRXS $3.78
- BFRG $2.68
- Average True Range (ATR)
- NRXS 0.42
- BFRG 0.19
- MACD
- NRXS 0.07
- BFRG -0.00
- Stochastic Oscillator
- NRXS 63.58
- BFRG 33.33
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
About BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.